A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes

Clinical trial NCT02806960 · TERMINATED

Trial details

NCT number: NCT02806960
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2014-06-01
Primary completion: 2014-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.